The shift to a one-week treatment promises substantial benefits at both the individual and societal level. For newborns, it means a 50% reduction in hospital stay, lowering healthcare costs, and minimising the danger of acquiring hospital-borne infections.
Related Posts
Competition Commission clears Apollo Hospital’s group entities restructuring plan
Post Views: 11 As part of the transaction, the identified…
Police teams arrest TN based cough syrup pharma owner in Chennai
Post Views: 15 According to the police official, the police…
FSSAI bans use of ‘ORS’ on food products, withdraws earlier orders allowing term with disclaimers
Post Views: 4 In its October 14 order, the food…